Details for New Drug Application (NDA): 204696
✉ Email this page to a colleague
The generic ingredient in LINEZOLID is linezolid. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the linezolid profile page.
Summary for 204696
Tradename: | LINEZOLID |
Applicant: | Sagent Pharms Inc |
Ingredient: | linezolid |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 204696
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 200MG/100ML (2MG/ML) | ||||
Approval Date: | Mar 2, 2017 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 600MG/300ML (2MG/ML) | ||||
Approval Date: | Mar 2, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription